As of January 2026 NervGen Pharma has a market cap of S$0.56 Billion. This makes NervGen Pharma the world's 7443th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.